Pharmacist experts review the evolving HIV treatment landscape — from 2026 guideline updates and first-line standards of care, to identifying suppressed patients who may still benefit from a switch, to applying new data on long-acting injectables, two-drug regimens, and pipeline agents when matching patients to therapy.